#AANAM – Progression May Be Evident in About 1.5 Years of Radicava Start

#AANAM – Progression May Be Evident in About 1.5 Years of Radicava Start

293102

#AANAM – Progression May Be Evident in About 1.5 Years of Radicava Start

Editor’s note: The ALS News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference. Amyotrophic lateral sclerosis (ALS) patients require walking aids, ventilation support, and/or speech generation devices about 1.5 years after starting treatment with Radicava (edaravone), according to data from U.S. insurance health claims. These real-world findings may help to inform patients, caregivers, and healthcare providers in estimating the time to disease progression milestones, and…

You must be logged in to read/download the full post.